**Selected for 2026 Doody's Core Titles in Cardiology**
Part of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Inside Front Cover - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Foreword - p. iii 8. Preface - p. iii 9. Acknowledgments - p. iii 10. Braunwald—s Heart Disease Family of Books - p. iii 11. List of Tables - p. iii 12. Section I: Epidemiology and Preventive Strategies - p. iii 13. Chapter 1: General Population and Global Cardiovascular Risk Prediction - p. iii 14. Chapter 2: Diet and Hypertension - p. iii 15. Chapter 3: Exercise and Hypertension - p. iii 16. Chapter 4: Hypertension in Women - p. iii 17. Section II: Pathophysiology - p. iii 18. Chapter 5: Pathophysiology of Hypertension - p. iii 19. Chapter 6: Genetics of Hypertension - p. iii 20. Chapter 7: Inflammation and Immunity in Hypertension - p. iii 21. Section III: Diagnosis and Evaluation - p. iii 22. Chapter 8: The Environment and High Blood Pressure - p. iii 23. Chapter 9: Office Blood Pressure Measurement - p. iii 24. Chapter 10: Home Monitoring of Blood Pressure - p. iii 25. Chapter 11: Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management - p. iii 26. Chapter 12: White Coat and Masked Hypertension - p. iii 27. Chapter 13: Renovascular Hypertension and Ischemic Nephropathy - p. iii 28. Chapter 14: Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States - p. iii 29. Chapter 15: Secondary Hypertension: Pheochromocytoma and Paraganglioma - p. iii 30. Chapter 16: Sleep Disruption and Blood Pressure - p. iii 31. Section IV: Risk Stratification - p. iii 32. Chapter 17: The Natural History of Untreated Hypertension - p. iii 33. Chapter 18: Isolated Systolic Hypertension - p. iii 34. Chapter 19: Assessment of Hypertension-Mediated Organ Damage - p. iii 35. Section V: Antihypertensive Therapy - p. iii 36. Chapter 20: Diuretics Therapy - p. iii 37. Chapter 21: Calcium Channel Blockers - p. iii 38. Chapter 22: Renin Angiotensin Aldosterone System Blockers - p. iii 39. Chapter 23: Aldosterone and Hypertension - p. iii 40. Chapter 24: β-Blockers, Central Sympathetic Agents, and Direct Vasodilators - p. iii 41. Chapter 25: Peripheral Alpha Blockers - p. iii 42. Chapter 26: Initial Combination Therapies - p. iii 43. Chapter 27: Device Therapies for Hypertension - p. iii 44. Chapter 28: The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle - p. iii 45. Section VI: Hypertension Management Approaches - p. iii 46. Chapter 29: Approach to Difficult to Manage Primary Hypertension - p. iii 47. Chapter 30: Team-Based Care for Hypertension Management - p. iii 48. Chapter 31: Medication Adherence: Focus on Improvement - p. iii 49. Chapter 32: Digital Health and Telemedicine for Hypertension - p. iii 50. Section VII: Hypertension Management With Comorbidities - p. iii 51. Chapter 33: Ischemic Heart Disease - p. iii 52. Chapter 34: Heart Failure - p. iii 53. Chapter 35: Hypertension and Chronic Kidney Disease Including Dialysis - p. iii 54. Chapter 36: Transplant Hypertension - p. iii 55. Chapter 37: Obesity and Hypertension: Pathophysiology and Treatment - p. iii 56. Chapter 38: Cerebrovascular Disease - p. iii 57. Chapter 39: Diabetes Mellitus: - p. iii 58. Chapter 40: Onco-Hypertension: Anticancer Therapy-Associated Hypertension - p. iii 59. Chapter 41: Autonomic Dysfunction and Orthostatic Hypotension - p. iii 60. Chapter 42: Dyslipidemia - p. iii 61. Chapter 43: Aorta and Peripheral Arterial Disease in Hypertension - p. iii 62. Section VIII: Special Populations - p. iii 63. Chapter 44: Hypertension in Pregnancy - p. iii 64. Chapter 45: Hypertension in Older People - p. iii 65. Chapter 46: Hypertension in African Americans - p. iii 66. Chapter 47: Resistant Hypertension - p. iii 67. Chapter 48: Hypertensive Emergencies and Urgencies - p. iii 68. Chapter 49: Hypertension in Children: Diagnosis and Treatment - p. iii 69. Meta-Analyses of Blood Pressure Lowering Trials - p. iii 70. Index - p. iii 71. Inside Back Cover - p. iii
**Selected for 2026 Doody's Core Titles in Cardiology**
Part of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Inside Front Cover - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Foreword - p. iii 8. Preface - p. iii 9. Acknowledgments - p. iii 10. Braunwald—s Heart Disease Family of Books - p. iii 11. List of Tables - p. iii 12. Section I: Epidemiology and Preventive Strategies - p. iii 13. Chapter 1: General Population and Global Cardiovascular Risk Prediction - p. iii 14. Chapter 2: Diet and Hypertension - p. iii 15. Chapter 3: Exercise and Hypertension - p. iii 16. Chapter 4: Hypertension in Women - p. iii 17. Section II: Pathophysiology - p. iii 18. Chapter 5: Pathophysiology of Hypertension - p. iii 19. Chapter 6: Genetics of Hypertension - p. iii 20. Chapter 7: Inflammation and Immunity in Hypertension - p. iii 21. Section III: Diagnosis and Evaluation - p. iii 22. Chapter 8: The Environment and High Blood Pressure - p. iii 23. Chapter 9: Office Blood Pressure Measurement - p. iii 24. Chapter 10: Home Monitoring of Blood Pressure - p. iii 25. Chapter 11: Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management - p. iii 26. Chapter 12: White Coat and Masked Hypertension - p. iii 27. Chapter 13: Renovascular Hypertension and Ischemic Nephropathy - p. iii 28. Chapter 14: Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States - p. iii 29. Chapter 15: Secondary Hypertension: Pheochromocytoma and Paraganglioma - p. iii 30. Chapter 16: Sleep Disruption and Blood Pressure - p. iii 31. Section IV: Risk Stratification - p. iii 32. Chapter 17: The Natural History of Untreated Hypertension - p. iii 33. Chapter 18: Isolated Systolic Hypertension - p. iii 34. Chapter 19: Assessment of Hypertension-Mediated Organ Damage - p. iii 35. Section V: Antihypertensive Therapy - p. iii 36. Chapter 20: Diuretics Therapy - p. iii 37. Chapter 21: Calcium Channel Blockers - p. iii 38. Chapter 22: Renin Angiotensin Aldosterone System Blockers - p. iii 39. Chapter 23: Aldosterone and Hypertension - p. iii 40. Chapter 24: β-Blockers, Central Sympathetic Agents, and Direct Vasodilators - p. iii 41. Chapter 25: Peripheral Alpha Blockers - p. iii 42. Chapter 26: Initial Combination Therapies - p. iii 43. Chapter 27: Device Therapies for Hypertension - p. iii 44. Chapter 28: The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle - p. iii 45. Section VI: Hypertension Management Approaches - p. iii 46. Chapter 29: Approach to Difficult to Manage Primary Hypertension - p. iii 47. Chapter 30: Team-Based Care for Hypertension Management - p. iii 48. Chapter 31: Medication Adherence: Focus on Improvement - p. iii 49. Chapter 32: Digital Health and Telemedicine for Hypertension - p. iii 50. Section VII: Hypertension Management With Comorbidities - p. iii 51. Chapter 33: Ischemic Heart Disease - p. iii 52. Chapter 34: Heart Failure - p. iii 53. Chapter 35: Hypertension and Chronic Kidney Disease Including Dialysis - p. iii 54. Chapter 36: Transplant Hypertension - p. iii 55. Chapter 37: Obesity and Hypertension: Pathophysiology and Treatment - p. iii 56. Chapter 38: Cerebrovascular Disease - p. iii 57. Chapter 39: Diabetes Mellitus: - p. iii 58. Chapter 40: Onco-Hypertension: Anticancer Therapy-Associated Hypertension - p. iii 59. Chapter 41: Autonomic Dysfunction and Orthostatic Hypotension - p. iii 60. Chapter 42: Dyslipidemia - p. iii 61. Chapter 43: Aorta and Peripheral Arterial Disease in Hypertension - p. iii 62. Section VIII: Special Populations - p. iii 63. Chapter 44: Hypertension in Pregnancy - p. iii 64. Chapter 45: Hypertension in Older People - p. iii 65. Chapter 46: Hypertension in African Americans - p. iii 66. Chapter 47: Resistant Hypertension - p. iii 67. Chapter 48: Hypertensive Emergencies and Urgencies - p. iii 68. Chapter 49: Hypertension in Children: Diagnosis and Treatment - p. iii 69. Meta-Analyses of Blood Pressure Lowering Trials - p. iii 70. Index - p. iii 71. Inside Back Cover - p. iii
